Euthyroid hypothyrotropinemia in children of short stature.
Unique association of hypothyrotropinemia with euthyroidism was described in 2 children of short stature. Both had a history of intrauterine growth retardation (IUGR), but showed an appropriate growth rate after infancy (5 cm/y). Growth hormone secretion after provocation tests was normal, whereas TSH response to TRH was absent. With a highly sensitive TSH radioimmunoassay (RIA) and a specific RIA for TSH-alpha-subunit, both responded to a high dose of TRH stimulation. Serum thyroid hormones were within the normal range, while prolactin response to TRH was exaggerated. Exogenous thyroxine (T4) supplement in case 1 did not improve his growth rate, indicating absence of hypothyroidism. Case 2 was treated with stanozolol, which accelerated his growth velocity to 8 cm/y. During the treatment, serum T4 gradually decreased to 50% of the initial level, but blunted TSH response to TRH remained unchanged. These results indicate that their thyrotrophs are resistant to TRH stimulation and the pituitary setpoint of TSH release is unusually high. The exact mechanism involved in maintaining euthyroidism despite hypothyrotropinemia remains to be elucidated, but a common history of IUGR appears to play a role in producing this pituitary-thyroid state.
Sato
T
T
Department of Pediatrics, School of Medicine, Kanazawa University.
Hashimoto
H
H
Miyagawa
K
K
Sonoda
T
T
D001835:Body Weight; D002648:Child; D005317:Fetal Growth Retardation; D006130:Growth Disorders / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D008297:Male; D011863:Radioimmunoassay; D013197:Stanozolol / Q000627:therapeutic use; D013961:Thyroid Gland / Q000502:physiology*; D013972:Thyrotropin / Q000378:metabolism*; D013974:Thyroxine / Q000627:therapeutic use
D013197:Stanozolol; D013972:Thyrotropin; D013974:Thyroxine